Who we are
We are a multi-disciplinary group of diverse scientists, physicians and learners from various backgrounds coming together to address important questions using novel techniques to help improve the care of patients with concurrent cardiovascular disease and cancer, as well as those with cardiac immune diseases. Our group values passion, curiosity, dedication and collegiality.
Dr. Han Zhu
Director, Stanford Translational Cardio-Oncology Program
Cardio-Oncology/Cardio-Immunology
Assistant Professor of Medicine
Dr. Zhu is an Assistant Professor of Medicine whose clinical and research expertise focuses on cardio-oncology and cardio-immunology. She specializes in the cardiovascular care of patients undergoing therapies for cancer, with a particular focus on the effects of immunotherapies on the heart. She received a bioengineering degree from MIT, medical degree from Case Western Reserve University, and completed clinical cardiology fellowship and internal medicine residency training at Stanford University School of Medicine. Dr. Zhu’s laboratory focuses on myocarditis, cardiac inflammation, and the effects of cancer therapeutics on the cardiovascular system. Her current research employs clinical data, bio-banked samples, and in vivo/in vitro preclinical models in combination with single-cell technologies to study immune-based toxicities in the heart. Dr. Zhu's clinic sees cardio-oncology and cardio-immunology patients and her lab focuses on devising new methods for minimizing cardiovascular complications in the cancer and autoimmune patient populations.

Basic/Translational Research Team
Clinical/Translational Research Team
Alumni & Past Affiliates
Daniel Lee
Julia Ryan
Sarah Waliany, MD
Maja Ivanovic, MD
Muhammed Fazal, MD
Rania Abdusamad
Antonia (Toni) Chan
Joaquin Parilla-Garcia
Andrew Nguyen, MD​
​